Market Research Logo

Venezuela Pharmaceuticals & Healthcare Q4 2019

Venezuela Pharmaceuticals & Healthcare Q4 2019

Key View:

Our outlook for the Venezuelan pharmaceutical market remains grim, as the full-blown economic, political andhumanitarian crisis continues to deteriorate the healthcare system. Many multinational drugmakers have all but abandonedoperations in the Latin American country following huge inflation-related hits to revenue. An escalation in the US sanction regimeon Venezuela will also likely make foreign firms extremely hesitant to interact with private businesses. As such, Venezuela will remainone of the most unattractive pharmaceutical and healthcare markets globally.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Boehringer Ingelheim
Calox International
Laboratorios Elmor
GlaxoSmithKline
Grupo Farma
Merck & Co
Novartis
Pfizer
Sanofi
Venezuela Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook